In situ histone landscape of nephrogenesis

Epigenetics

Volumn 9, Issue 2, 2014, Pages 222-235

  McLaughlin, Nathan ^a   Wang, Fenglin ^a   Saifudeen, Zubaida ^a   El Dahr, Samir S ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chromatin landscape; Differentiation; Histone methylation; Histone modifications; Kidney development; Nephrogenesis; Nephron progenitors

Indexed keywords

ARGININE; BIOLOGICAL MARKER; HISTONE LYSINE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE; TRANSCRIPTION FACTOR; HISTONE; LYSINE;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BLADDER DIVERTICULUM; CELL DIFFERENTIATION; CELL PROLIFERATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GENETIC REGULATION; GROWTH INHIBITION; HISTONE METHYLATION; IMMUNOFLUORESCENCE; IMMUNOLOCALIZATION; KIDNEY DEVELOPMENT; MOUSE; NEPHRON; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; URETER; WESTERN BLOTTING; ANIMAL; CHROMATIN; CHROMATIN LANDSCAPE; CYTOLOGY; DIFFERENTIATION; HISTONE MODIFICATIONS; KIDNEY; METABOLISM; METHYLATION; NEPHROGENESIS; NEPHRON PROGENITORS; ORGANOGENESIS; PRENATAL DEVELOPMENT; STEM CELL;

CHROMATIN LANDSCAPE; DIFFERENTIATION; HISTONE METHYLATION; HISTONE MODIFICATIONS; KIDNEY DEVELOPMENT; NEPHROGENESIS; NEPHRON PROGENITORS;

ANIMALS; ARGININE; CELL DIFFERENTIATION; CHROMATIN; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; KIDNEY; LYSINE; METHYLATION; MICE; NEPHRONS; ORGANOGENESIS; STEM CELLS;

EID: 84892577376     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.26793     Document Type: Article

References (53)

1. Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol 2010; 28:1057-68; PMID:20944598; http://dx.doi.org/10.1038/ nbt.1685
2. Huang C, Sloan EA, Boerkoel CF. Chromatin remodeling and human disease. Curr Opin Genet Dev 2003; 13:246-52; PMID:12787786; http:// dx.doi.org/10.1016/S0959-437X(03)00054-6
3. Strahl BD, Allis CD. The language of covalent histone modifications. Nature 2000; 403:41-5; PMID:10638745; http://dx.doi.org/10.1038/47412
4. Campos EI, Reinberg D. Histones: annotating chromatin. Annu Rev Genet 2009; 43:559-99; PMID:19886812; http://dx.doi.org/10.1146/ annurev.genet.032608.103928
5. Chan KM, Fang D, Gan H, Hashizume R, Yu C, Schroeder M, Gupta N, Mueller S, James CD, Jenkins R, et al. The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression. Genes Dev 2013; 27:985-90; PMID:23603901; http://dx.doi.org/10.1101/ gad.217778.113
6. Xu CR, Cole PA, Meyers DJ, Kormish J, Dent S, Zaret KS. Chromatin "prepattern" and histone modifiers in a fate choice for liver and pancreas. Science 2011; 332:963-6; PMID:21596989; http://dx.doi. org/10.1126/science.1202845
7. Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 2011; 470:279-83; PMID:21160473; http:// dx.doi.org/10.1038/nature09692
8. Magklara A, Yen A, Colquitt BM, Clowney EJ, Allen W, Markenscoff-Papadimitriou E, Evans ZA, Kheradpour P, Mountoufaris G, Carey C, et al. An epigenetic signature for monoallelic olfactory receptor expression. Cell 2011; 145:555-70; PMID:21529909; http://dx.doi.org/10.1016/j.cell.2011.03.040
9. Cui K, Zang C, Roh TY, Schones DE, Childs RW, Peng W, Zhao K. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 2009; 4:80-93; PMID:19128795; http://dx.doi. org/10.1016/j.stem.2008.11.011
10. Azuara V, Perry P, Sauer S, Spivakov M, Jørgensen HF, John RM, Gouti M, Casanova M, Warnes G, Merkenschlager M, et al. Chromatin signatures of pluripotent cell lines. Nat Cell Biol 2006; 8:532-8; PMID:16570078; http://dx.doi.org/10.1038/ ncb1403
11. Akhtar-Zaidi B, Cowper-Sal-lari R, Corradin O, Saiakhova A, Bartels CF, Balasubramanian D, Myeroff L, Lutterbaugh J, Jarrar A, Kalady MF, et al. Epigenomic enhancer profiling defines a signature of colon cancer. Science 2012; 336:736-9; PMID:22499810; http://dx.doi.org/10.1126/ science.1217277
12. Mugford JW, Sipilä P, McMahon JA, McMahon AP. Osr1 expression demarcates a multi-potent population of intermediate mesoderm that undergoes progressive restriction to an Osr1-dependent nephron progenitor compartment within the mammalian kidney. Dev Biol 2008; 324:88-98; PMID:18835385; http://dx.doi.org/10.1016/j.ydbio.2008.09.010
13. Park JS, Valerius MT, McMahon AP. Wnt/betacatenin signaling regulates nephron induction during mouse kidney development. Development 2007; 134:2533-9; PMID:17537789; http://dx.doi. org/10.1242/dev.006155
14. Park JS, Ma W, O'Brien LL, Chung E, Guo JJ, Cheng JG, Valerius MT, McMahon JA, Wong WH, McMahon AP. Six2 and Wnt regulate selfrenewal and commitment of nephron progenitors through shared gene regulatory networks. Dev Cell 2012; 23:637-51; PMID:22902740; http://dx.doi. org/10.1016/j.devcel.2012.07.008
15. Karner CM, Das A, Ma Z, Self M, Chen C, Lum L, Oliver G, Carroll TJ. Canonical Wnt9b signaling balances progenitor cell expansion and differentiation during kidney development. Development 2011; 138:1247-57; PMID:21350016; http://dx.doi. org/10.1242/dev.057646
16. McLaughlin N, Yao X, Li Y, Saifudeen Z, El-Dahr SS. Histone signature of metanephric mesenchyme cell lines. Epigenetics 2013; 8: 970-978; PMID:23867747; http://dx.doi.org/10.4161/ epi.25753
17. Torres-Padilla ME, Parfitt DE, Kouzarides T, Zernicka-Goetz M. Histone arginine methylation regulates pluripotency in the early mouse embryo. Nature 2007; 445:214-8; PMID:17215844; http:// dx.doi.org/10.1038/nature05458
18. Pan G, Tian S, Nie J, Yang C, Ruotti V, Wei H, Jonsdottir GA, Stewart R, Thomson JA. Wholegenome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Cell Stem Cell 2007; 1:299-312; PMID:18371364; http://dx.doi.org/10.1016/j.stem.2007.08.003
19. Sawan C, Herceg Z. Histone modifications and cancer. Adv Genet 2010; 70:57-85; PMID:20920745; http:// dx.doi.org/10.1016/B978-0-12-380866-0.60003-4
20. Park YS, Jin MY, Kim YJ, Yook JH, Kim BS, Jang SJ. The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma. Ann Surg Oncol 2008; 15:1968-76; PMID:18470569; http://dx.doi.org/10.1245/ s10434-008-9927-9
21. Seligson DB, Horvath S, Shi T, Yu H, Tze S, Grunstein M, Kurdistani SK. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 2005; 435:1262-6; PMID:15988529; http://dx.doi.org/10.1038/nature03672
22. Shilatifard A. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu Rev Biochem 2006; 75:243-69; PMID:16756492; http://dx.doi. org/10.1146/annurev.biochem.75.103004.142422
23. Eissenberg JC, Shilatifard A. Histone H3 lysine 4 (H3K4) methylation in development and differentiation. Dev Biol 2010; 339:240-9; PMID:19703438; http://dx.doi.org/10.1016/j.ydbio.2009.08.017
24. Zhou VW, Goren A, Bernstein BE. Charting histone modifications and the functional organization of mammalian genomes. Nat Rev Genet 2011; 12:7-18; PMID:21116306; http://dx.doi.org/10.1038/ nrg2905
25. Sauvageau M, Sauvageau G. Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer. Cell Stem Cell 2010; 7:299-313; PMID:20804967; http://dx.doi.org/10.1016/j. stem.2010.08.002
26. Christophersen NS, Helin K. Epigenetic control of embryonic stem cell fate. J Exp Med 2010; 207:2287-95; PMID:20975044; http://dx.doi.org/10.1084/ jem.20101438
27. Mohan M, Herz HM, Takahashi YH, Lin C, Lai KC, Zhang Y, Washburn MP, Florens L, Shilatifard A. Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom). Genes Dev 2010; 24:574-89; PMID:20203130; http://dx.doi.org/10.1101/gad.1898410
28. Jones B, Su H, Bhat A, Lei H, Bajko J, Hevi S, Baltus GA, Kadam S, Zhai H, Valdez R, et al. The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure. PLoS Genet 2008; 4:e1000190; PMID:18787701; http://dx.doi.org/10.1371/journal.pgen.1000190
29. Patel SR, Kim D, Levitan I, Dressler GR. The BRCTdomain containing protein PTIP links PAX2 to a histone H3, lysine 4 methyltransferase complex. Dev Cell 2007; 13:580-92; PMID:17925232; http:// dx.doi.org/10.1016/j.devcel.2007.09.004
30. Aldiri I, Vetter ML. PRC2 during vertebrate organogenesis: a complex in transition. Dev Biol 2012; 367:91-9; PMID:22565092; http://dx.doi. org/10.1016/j.ydbio.2012.04.030
31. Ezhkova E, Lien WH, Stokes N, Pasolli HA, Silva JM, Fuchs E. EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair. Genes Dev 2011; 25:485-98; PMID:21317239; http://dx.doi. org/10.1101/gad.2019811
32. Shinkai Y, Tachibana M. H3K9 methyltransferase G9a and the related molecule GLP. Genes Dev 2011; 25:781-8; PMID:21498567; http://dx.doi. org/10.1101/gad.2027411
33. Kirmizis A, Santos-Rosa H, Penkett CJ, Singer MA, Vermeulen M, Mann M, Bähler J, Green RD, Kouzarides T. Arginine methylation at histone H3R2 controls deposition of H3K4 trimethylation. Nature 2007; 449:928-32; PMID:17898715; http://dx.doi. org/10.1038/nature06160
34. Guccione E, Bassi C, Casadio F, Martinato F, Cesaroni M, Schuchlautz H, Lüscher B, Amati B. Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive. Nature 2007; 449:933-7; PMID:17898714; http://dx.doi. org/10.1038/nature06166
35. Pal S, Baiocchi RA, Byrd JC, Grever MR, Jacob ST, Sif S. Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma. EMBO J 2007; 26:3558-69; PMID:17627275; http://dx.doi.org/10.1038/ sj.emboj.7601794
36. Majumder S, Alinari L, Roy S, Miller T, Datta J, Sif S, Baiocchi R, Jacob ST. Methylation of histone H3 and H4 by PRMT5 regulates ribosomal RNA gene transcription. J Cell Biochem 2010; 109:553-63; PMID:19998411
37. Dacwag CS, Ohkawa Y, Pal S, Sif S, Imbalzano AN. The protein arginine methyltransferase Prmt5 is required for myogenesis because it facilitates ATPdependent chromatin remodeling. Mol Cell Biol 2007; 27:384-94; PMID:17043109; http://dx.doi. org/10.1128/MCB.01528-06
38. Yang Y, Lu Y, Espejo A, Wu J, Xu W, Liang S, Bedford MT. TDRD3 is an effector molecule for argininemethylated histone marks. Mol Cell 2010; 40:1016-23; PMID:21172665; http://dx.doi.org/10.1016/j. molcel.2010.11.024
39. Frietze S, Lupien M, Silver PA, Brown M. CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1. Cancer Res 2008; 68:301-6; PMID:18172323; http://dx.doi. org/10.1158/0008-5472.CAN-07-1983
40. McMahon AP, Aronow BJ, Davidson DR, Davies JA, Gaido KW, Grimmond S, Lessard JL, Little MH, Potter SS, Wilder EL, et al.; GUDMAP project. GUDMAP: the genitourinary developmental molecular anatomy project. J Am Soc Nephrol 2008; 19:667-71; PMID:18287559; http://dx.doi. org/10.1681/ASN.2007101078
41. Black JC, Choi JE, Lombardo SR, Carey M. A mechanism for coordinating chromatin modification and preinitiation complex assembly. Mol Cell 2006; 23:809-18; PMID:16973433; http://dx.doi. org/10.1016/j.molcel.2006.07.018
42. Stein AB, Jones TA, Herron TJ, Patel SR, Day SM, Noujaim SF, Milstein ML, Klos M, Furspan PB, Jalife J, et al. Loss of H3K4 methylation destabilizes gene expression patterns and physiological functions in adult murine cardiomyocytes. J Clin Invest 2011; 121:2641-50; PMID:21646717; http://dx.doi. org/10.1172/JCI44641
43. Kim D, Wang M, Cai Q, Brooks H, Dressler GR. Pax transactivation-domain interacting protein is required for urine concentration and osmotolerance in collecting duct epithelia. J Am Soc Nephrol 2007; 18:1458-65; PMID:17429055; http://dx.doi. org/10.1681/ASN.2006060625
44. Biron VL, McManus KJ, Hu N, Hendzel MJ, Underhill DA. Distinct dynamics and distribution of histone methyl-lysine derivatives in mouse development. Dev Biol 2004; 276:337-51; PMID:15581869; http://dx.doi.org/10.1016/j.ydbio.2004.08.038
45. Pan Z, Zhang J, Li Q, Li Y, Shi F, Xie Z, Liu H. Current advances in epigenetic modification and alteration during mammalian ovarian folliculogenesis. J Genet Genomics 2012; 39:111-23; PMID:22464470; http://dx.doi.org/10.1016/j. jgg.2012.02.004
46. Steger DJ, Lefterova MI, Ying L, Stonestrom AJ, Schupp M, Zhuo D, Vakoc AL, Kim JE, Chen J, Lazar MA, et al. DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Mol Cell Biol 2008; 28:2825-39; PMID:18285465; http://dx.doi. org/10.1128/MCB.02076-07
47. Nguyen AT, Zhang Y. The diverse functions of Dot1 and H3K79 methylation. Genes Dev 2011; 25:1345-58; PMID:21724828; http://dx.doi.org/10.1101/ gad.2057811
48. Wu H, Chen L, Zhou Q, Zhang X, Berger S, Bi J, Lewis DE, Xia Y, Zhang W. Aqp2-expressing cells give rise to renal intercalated cells. J Am Soc Nephrol 2013; 24:243-52; PMID:23308014; http://dx.doi. org/10.1681/ASN.2012080866
49. Tae S, Karkhanis V, Velasco K, Yaneva M, Erdjument-Bromage H, Tempst P, Sif S. Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes. Nucleic Acids Res 2011; 39:5424-38; PMID:21447565; http://dx.doi.org/10.1093/nar/ gkr170
50. Pal S, Vishwanath SN, Erdjument-Bromage H, Tempst P, Sif S. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol Cell Biol 2004; 24:9630-45; PMID:15485929; http://dx.doi.org/10.1128/ MCB.24.21.9630-9645.2004
51. Chen S, Bellew C, Yao X, Stefkova J, Dipp S, Saifudeen Z, Bachvarov D, El-Dahr SS. Histone deacetylase (HDAC) activity is critical for embryonic kidney gene expression, growth, and differentiation. J Biol Chem 2011; 286:32775-89; PMID:21778236; http://dx.doi.org/10.1074/jbc.M111.248278
52. Saifudeen Z, Liu J, Dipp S, Yao X, Li Y, McLaughlin N, Aboudehen K, El-Dahr SS. A p53-Pax2 pathway in kidney development: implications for nephrogenesis. PLoS One 2012; 7:e44869; PMID:22984579; http://dx.doi.org/10.1371/journal.pone.0044869
53. Aboudehen K, Hilliard S, Saifudeen Z, El-Dahr SS. Mechanisms of p53 activation and physiological relevance in the developing kidney. Am J Physiol Renal Physiol 2012; 302:F928-40; PMID:22237799; http://dx.doi.org/10.1152/ajprenal.00642.2011